Lai, Alvina G. http://orcid.org/0000-0001-8960-8095
Chang, Wai Hoong
Parisinos, Constantinos A.
Katsoulis, Michail
Blackburn, Ruth M.
Shah, Anoop D.
Nguyen, Vincent
Denaxas, Spiros
Davey Smith, George
Gaunt, Tom R.
Nirantharakumar, Krishnarajah
Cox, Murray P.
Forde, Donall
Asselbergs, Folkert W.
Harris, Steve
Richardson, Sylvia
Sofat, Reecha
Dobson, Richard J. B.
Hingorani, Aroon
Patel, Riyaz
Sterne, Jonathan
Banerjee, Amitava
Denniston, Alastair K.
Ball, Simon
Sebire, Neil J.
Shah, Nigam H.
Foster, Graham R.
Williams, Bryan
Hemingway, Harry
Funding for this research was provided by:
Wellcome Trust (204841/Z/16/Z)
Article History
Received: 19 April 2021
Accepted: 27 September 2021
First Online: 12 October 2021
Declarations
:
: We obtained informational governance approval from the Medicines Healthcare Regulatory Authority (UK) Independent Scientific Advisory Committee (20_078R) to analyse the Clinical Practice Research Datalink (CPRD) linked to secondary care Hospital Episode Statistics and the Office for National Statistic death registration. Ethics approval was exempted for the survey as it is classified under service evaluation. Survey participants gave informed consent to participate by returning the completed survey.
: Not applicable.
: AB has received research funding from AstraZeneca for work unrelated to this research. GRF receives funding from companies that manufacture drugs for hepatitis C virus (AbbVie, Gilead, MSD) and consults for GSK, Arbutus and Shionogi in areas unrelated to this research. TRG and GDS have received research funding from GlaxoSmithKline and Biogen for work unrelated to this research.